Jonathan A. Busam

ORCID: 0000-0002-1905-5170

MedicineBiochemistry, Genetics and Molecular BiologyHealth Professions

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 2 papers. Top paper: “Cost-effectiveness of DPYD Genotyping Prior to Fluoropyrimidine-based Adjuvant Chemotherapy for Colon Cancer”.

Cost-effectiveness of DPYD Genotyping Prior to Fluoropyrimidine-based Adjuvant Chemotherapy for Colon Cancer

Clinical Colorectal Cancer(2022)10.1016/j.clcc.2022.05.001

N/A

0DataRank · unranked

40 citations

Stephanie Tapp, Allan T. Daly, Jonathan A. Busam, Anna N.A. Tosteson, Gabriel A. Brooks

Clinical Evidence to Support US Food and Drug Administration Review of New Medical Technology in Pulmonary, Sleep, and Critical Care Medicine Between 2014 and 2024

CHEST Journal(2025)10.1016/j.chest.2025.12.012

N/A

0DataRank · unranked

0 citations

Jonathan A. Busam, Eric D. Shah, Jack T. Gardner